跳至主要内容
临床试验/NCT07027280
NCT07027280招募中不适用

Noninvasive Intratumor Heterogeneity Evaluation in HNSCC With Multi-omics Insights and Therapeutic Targets

First Affiliated Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2025年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
700
试验地点
1
主要终点
AUC

研究概览

简要总结

This study focuses on tumor heterogeneity, a core challenge in the field of oncology, and innovatively utilizes patient imaging data to deeply mine and analyze intratumoral heterogeneity. By constructing an imaging analysis model for tumor heterogeneity and associating this model with clinical, pathological, transcriptomic, and metabolomic data of patients, a multi-omics decoding of tumor heterogeneity is achieved. The main questions it aims to address are:

Can the ITH model stratify patients' treatment efficacy and prognosis assessment? Can pathological and multi-omics sequencing map the mechanisms behind the ITH model?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 89 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Pathologically confirmed head and neck squamous cell carcinoma (HNSCC). Complete clinical, imaging, and pathological data. Available complete follow-up information.

排除标准

  • •Patients who received chemotherapy or radiotherapy before surgery. Poor image quality. Tumors too small to be easily identified. History of other concurrent malignant tumors.

结局指标

主要结局

AUC

时间窗: through study completion, an average of 1 year

C-index

时间窗: through study completion, an average of 1 year

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

xinwei Chen

PHD

First Affiliated Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验